The StartX Med COVID-19 Task Force includes more than 70 scientists, physicians and professor entrepreneurs from the community who are working together to accelerate government and regulatory agency approval of digital solutions to prevent, diagnose and treat the disease caused by the novel coronavirus. They will also collaborate with hospitals and health systems to integrate the tools into workflows.
The task force’s portfolio includes rapid testing solutions; remote monitoring applications; automated quarantine management and remote virtual triage tools; handheld devices to measure temperature, lung sounds, airway pressure and more; and free access to research platforms for biopharmaceutical companies developing vaccines, among many others.
Participating healthcare technology startups include Qventus, Eko, Bright.md, Wellsheet and several more.
“As the number of positive cases continue to soar in the outbreak of COVID-19, there is an imminent need for reducing barriers companies are experiencing with therapeutic medical breakthroughs needing to be deployed,” Joseph Huang, CEO of StartX, said in a statement.
More articles on innovation:
Hartford HealthCare funnels $14M into tech-focused venture studio & access center
Mount Sinai spinout unveils digital toolkit to help hospitals triage, monitor COVID-19
Hackensack Meridian innovation center launches diagnostic tool to speed COVID-19 tests
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
